Analysts Downgraded Ratings on These Company Shares Today

Following is information on companies for which stock analysts downgraded the shares today:

  • Anthera Pharma (NASDAQ:ANTH): Wedbush downgraded its rating on this stock from Outperform to Neutral and changed its price target from $9 to $7.  About the company: Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.
  • Sun Healthcare (NASDAQ:SUNH): Oppenheimer downgraded its rating on this stock from Outperform to Underperform.  No price target was given. Morgan Keegan downgraded its rating on this stock from Outperform to Mkt Perform and changed its price target from $11 to $4.  About the company:  Sabra Health Care REIT, Inc. is a real estate investment trust. The trust owns nursing homes, rehabilitation centers, assisted living facilities, and independent living centers.
  • National Healthcare (AMEX:NHC): Morgan Keegan downgraded its rating on this stock from Outperform to Mkt Perform and changed its price target from $55 to $41.  About the company:  National Healthcare Corporation operates long-term health care centers. The Company also operates homecare programs, independent living centers, and assisted living centers. National Healthcare’s other services include managed care specialty medical units, Alzheimer’s units, and a rehabilitation services company.
  • Skilled Healthcare (NYSE:SKH): Morgan Keegan downgraded its rating on this stock from Outperform to Mkt Perform and changed its price target from $14 to $6.75.  About the company: Skilled Healthcare Group Inc. operates nursing and assisted-living homes in California, Texas, Kansas, and Nevada.

(Note: Data on stock ratings are sourced from here.  All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter >>

More from The Cheat Sheet